Advanced glycation end-products impair Na+/K+-ATPase activity in diabetic cardiomyopathy: Role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 2, 2014, Pages 127-133

  Yuan, Qiong ^a   Zhou, Qian Yi ^a   Liu, Du ^a   Yu, Lun ^a   Zhan, Lin ^a   Li, Xiao Jing ^a   Peng, Hong Yan ^a   Zhang, Xiu Ling ^b   Yuan, Xin Chu ^a  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Hematology   (China)

Author keywords

Adenosine monophosphate activated protein kinase; Diabetic cardiomyopathy; Sirtuin 1

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADVANCED GLYCATION END PRODUCT; ENZYME INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; SIRTUIN 1; SPLITOMICIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVITY; HEART MUSCLE CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEWBORN; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE; DIABETIC CARDIOMYOPATHY; NA+/K+-ATPASE; SIRTUIN 1;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART FUNCTION TESTS; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SIRTUIN 1; SODIUM-POTASSIUM-EXCHANGING ATPASE; STREPTOZOCIN; VENTRICULAR FUNCTION, LEFT;

EID: 84897501364     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12194     Document Type: Article

References (38)

1. Bidasee KR, Zhang Y, Shao CH et al. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 2004; 53: 463-73.
2. Candido R, Forbes JM, Thomas MC et al. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ. Res. 2003; 92: 785-92.
3. Norton GR, Candy G, Woodiwiss AJ. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation 1996; 93: 1905-12.
4. Pierce GN, Dhalla NS. Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am. J. Physiol. 1983; 245: C241-7.
5. Dhalla NS, Rangi S, Zieroth S, Xu YJ. Alterations in sarcoplasmic reticulum and mitochondrial functions in diabetic cardiomyopathy. Exp. Clin. Cardiol. 2012; 17: 115-20.
6. Ver A, Szanto I, Banyasz T et al. Changes in the expression of Na+/K+-ATPase isoenzymes in the left ventricle of diabetic rat hearts: Effect of insulin treatment. Diabetologia 1997; 40: 1255-62.
7. Li Y, Li Y, Feng Q, Arnold M, Peng T. Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. Cardiovasc. Res. 2009; 84: 100-10.
8. Han DN, Zhang DH, Wang LP, Zhang YS. Protective effect of beta-casomorphin-7 on cardiomyopathy of streptozotocin-induced diabetic rats via inhibition of hyperglycemia and oxidative stress. Peptides 2013; 44: 120-6.
9. Imai S, Armstrong CM, Kaeberlein M, Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403: 795-800.
10. Smith JS, Brachmann CB, Celic I et al. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 6658-63.
11. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res. 2004; 95: 971-80.
12. Alcendor RR, Gao S, Zhai P et al. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 2007; 100: 1512-21.
13. Sulaiman M, Matta MJ, Sunderesan NR et al. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2010; 298: H833-43.
14. Chuang PY, Dai Y, Liu R et al. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS ONE 2011; 6: e23566.
15. Witczak CA, Sharoff CG, Goodyear LJ. AMP-activated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism. Cell. Mol. Life Sci. 2008; 65: 3737-55.
16. Canto C, Gerhart-Hines Z, Feige JN et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009; 458: 1056-60.
17. Chen S, Xiao X, Feng X et al. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression. J. Nutr. Biochem. 2012; 23: 1100-12.
18. Benziane B, Bjornholm M, Pirkmajer S et al. Activation of AMP-activated protein kinase stimulates Na+, K+-ATPase activity in skeletal muscle cells. J. Biol. Chem. 2012; 287: 23451-63.
19. Kim M, Shen M, Ngoy S et al. AMPK isoform expression in the normal and failing hearts. J. Mol. Cell. Cardiol. 2012; 52: 1066-73.
20. Paiva MA, Rutter-Locher Z, Goncalves LM et al. Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2011; 300: H2123-34.
21. Yue TL, Wang C, Gu JL et al. Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 2000; 86: 692-9.
22. Fraser SF, McKenna MJ. Measurement of Na+, K+-ATPase activity in human skeletal muscle. Anal. Biochem. 1998; 258: 63-7.
23. Jiang DJ, Jia SJ, Yan J et al. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem. Biophys. Res. Commun. 2006; 349: 683-93.
24. Kindermann M. How to diagnose diastolic heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007; 28: 2686; author reply 2686-2687.
25. Babu PV, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+-ATPase activity in the heart of streptozotocin-diabetic rats. Chem. Biol. Interact. 2006; 162: 157-64.
26. Banday AA, Lokhandwala MF. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Hypertension 2008; 52: 1099-105.
27. Bers DM, Despa S. Na/K-ATPase-an integral player in the adrenergic fight-or-flight response. Trends Cardiovasc. Med. 2009; 19: 111-18.
28. Oubaassine R, Weckering M, Kessler L et al. Insulin interacts directly with Na(+)/K(+)ATPase and protects from digoxin toxicity. Toxicology 2012; 299: 1-9.
29. Garlid KD, Costa AD, Quinlan CL, Pierre SV, Dos Santos P. Cardioprotective signaling to mitochondria. J. Mol. Cell. Cardiol. 2009; 46: 858-66.
30. Turrens JF. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003; 552: 335-44.
31. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82: 47-95.
32. Writing Committee M, Yancy CW, Jessup M et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 128: e240-319.
33. Kuno A, Hori YS, Hosoda R et al. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. J. Biol. Chem. 2013; 288: 5963-72.
34. Gundewar S, Calvert JW, Jha S et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res. 2009; 104: 403-11.
35. Fassett JT, Hu X, Xu X et al. AMPK attenuates microtubule proliferation in cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2013; 304: H749-58.
36. He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 2012; 62: 1270-81.
37. Ruderman NBMD, Xu XJPD, Nelson LE et al. AMPK and SIRT1: A longstanding partnership? Am. J. Physiol. Endocrinol. Metab. 2010; 298: e751-60.
38. Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009; 20: 98-105.